Urologic oncology
Alopecia following single-dose postoperative intravesical gemcitabine in nonmuscle-invasive bladder cancer: A multi-institutional case series.
Anosh Dadabhoy, Chirag Doshi, Mazyar Zahir, Sanam Ladi-Seyedian, Domenique Escobar, Leilei Xia, Anne Schuckman, Christopher B Anderson, Max Kates, Piyush K Agarwal, Seth P Lerner, Karim Chamie, Alon Weizer, Siamak Daneshmand
Published: 202610.1016/j.urolonc.2025.12.020
Abstract
INTRODUCTION: Single-dose intravesical gemcitabine therapy (IVGT) is a standard of care option following transurethral resection (TURBT) for low- to intermediate-risk nonmuscle invasive bladder cancer (NMIBC). The side-effect profile of IVGT has prim…
Preview only. Read the full abstract at the source